Department of Neonatology, Kunming Children's Hospital, Kunming 650228, Yunnan, China.
Kunming Key Laboratory of Children Infection and Immunity, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Institute of Pediatrics, Kunming Children's Hospital, Kunming 650228, Yunnan, China.
Medicine (Baltimore). 2022 Jul 8;101(27):e29239. doi: 10.1097/MD.0000000000029239.
Mitochondrial complex I deficiency (MCID) and abbFINCA syndrome are lethal congenital diseases and cases in the neonatal period are rarely reported. Here, we identified a Chinese Hani minority neonate with rare MCID and FINCA syndrome. This study was to analyze the clinical manifestations and pathogenic gene variations, and to investigate causes of quick postnatal death of patient and possible molecular pathogenic mechanisms.
A 17-day-old patient had reduced muscle tension, diminished primitive reflexes, significantly abnormal blood gas analysis, and progressively increased blood lactate and blood glucose. Imaging studies revealed pneumonia, pulmonary hypertension, and brain abnormalities.
Whole-exome sequencing revealed that the NDUFS6 gene of the patient carried c. 344G > T (p.C115F) novel homozygous variation, and the NHLRC2 gene carried c. 1749C > G (p.F583L) and c. 2129C > T (p.T710M) novel compound heterozygous variation.
The patient was given endotracheal intubation, respiratory support, high-frequency ventilation, antishock therapy, as well as iNO and Alprostadil to reduce pulmonary hypertension and maintain homeostatic equilibrium. However, the patient was critically ill and died in 27 days.
The patient has MCID due to a novel mutation in NDUFS6 and FINCA syndrome due to novel mutations in NHLRC2, which is the main reason for the rapid onset and quick death of the patient.
线粒体复合物 I 缺陷(MCID)和 abbFINCA 综合征是致命的先天性疾病,新生儿期的病例很少见报道。在这里,我们鉴定了一名患有罕见 MCID 和 FINCA 综合征的中国哈尼族新生儿。本研究旨在分析其临床表现和致病基因突变,并探讨导致患者快速产后死亡的原因和可能的分子发病机制。
一名 17 天大的患儿表现为肌张力降低、原始反射减弱、血气分析明显异常,血乳酸和血糖逐渐升高。影像学检查显示肺炎、肺动脉高压和脑异常。
全外显子组测序显示,患者的 NDUFS6 基因携带 c.344G>T(p.C115F) 新型纯合变异,NHLRC2 基因携带 c.1749C>G(p.F583L)和 c.2129C>T(p.T710M) 新型复合杂合变异。
患儿给予气管插管、呼吸支持、高频通气、抗休克治疗,以及 iNO 和 Alprostadil 降低肺动脉高压和维持内环境平衡。然而,患儿病情危重,27 天后死亡。
患者因 NDUFS6 中的新型突变而患有 MCID,因 NHLRC2 中的新型突变而患有 FINCA 综合征,这是导致患者快速发病和快速死亡的主要原因。